Jared Kushner admits he told Donald Trump about Donald

New Post Public Reply Private Reply Replies (0) Message Board

Jul 13, 2017 at 6:16 PM 273

Quote:

Jared Kushner admits he told Donald Trump about Donald Trump Jr.s Russia meeting

The NYTimes article that is mentioned in this article is below. The picture that is being developed is becoming a bit less murky (My analogy).

www.palmerreport.com/opinion/jared-kushner-admits-told-donald-trump-donald-trump-jr-s-russia-meeting/3837/

By Bill Palmer
Updated: 4:20 pm EDT Thu Jul 13, 2017 | 0

First came word from the New York Times that Donald Trump’s own attorneys think Jared Kushner is giving Trump bad advice on how to handle the Russia scandal, in the hope of protecting himself at Trump’s expense.

Now comes word that, long before the news of Donald Trump Jr.’s meeting with Russia hit the newswires, Kushner told Donald Trump about the meeting. This directly undermines Trump’s own current attempt at a defense.

When the Trump Jr. story broke in the media, Donald Trump tried to claim that he had just learned about the meeting in the few days before it hit the wires. This was an attempt on his part at insulating himself from the serious crimes his son committed.

But now the NY Times is reporting that Jared Kushner is admitting he told Donald Trump about the meeting back when he was revising the security clearance forms he had lied on (link). No specific timeframe is given for when he told him, but it would have been sometime around the end of May or the start of June.

And so Jared Kushner has just confirmed that Donald Trump is lying when he claims he didn’t learn about the meeting until a few days ago. It’s becoming more clear by the minute that Kushner is only interested in protecting himself.

He was the one who informed the Feds about Trump Jr.’s Russia meeting when he amended his clearance forms, meaning that he’s the one who put all of the current developments in motion – and he did that all to try to save himself from going to prison for lying on those forms..................................

https://www.nytimes.com/2017/07/12/us/politic....html?_r=0

With Glare on Trump Children, Political Gets Personal for President
Mark Landler and Maggie Haberman
9-11 minutes
...................While Donald Trump Jr. has been on the firing line, the meeting with Ms. Veselnitskaya could arguably be a bigger distraction for Mr. Kushner. As a senior adviser to the president, he is involved in several of the administration’s most sensitive foreign-policy issues, from China to the Middle East peace process. His involvement in the meeting led reporters to ask the White House whether he still held his security clearance.

Also under scrutiny is how forthcoming Mr. Kushner was with his father-in-law about the nature of the June meeting. He met with Mr. Trump to discuss the issue, according to advisers to the White House, around the time he updated his federal disclosure form to include Ms. Veselnitskaya’s name on a list of foreign contacts that Mr. Kushner was required to submit to the F.B.I. to obtain a security clearance.

Mr. Kushner supplemented the list of foreign contacts three times, adding more than 100 names, people close to him said.

Mr. Kushner played down the significance of the meeting and omitted significant details, according to two people who were briefed on the exchange. They said Mr. Kushner informed the president that he had met with a Russian foreign national, and that while he had to report the name, it would not cause a problem for the administration.

Another official said Mr. Kushner’s assurance to the president was based on the fact that nothing came of the June meeting.
.............
In an interview with Reuters, Mr. Trump said he had not been told last summer that his son was meeting with a Russian lawyer. “No, that I didn’t know until a couple of days ago when I heard about this,” he said..........................

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Fibocom LTE Modules Test Drive Satellite Connectivity

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...